Does getting older increase aspirin-related bleeding risk?
Yes. Age is a major risk factor for bleeding with aspirin, including gastrointestinal (GI) bleeding and bleeding that requires medical attention. As people get older, the baseline risk of bleeding rises, and aspirin adds further risk. This is one reason clinicians often reassess whether the benefits of aspirin still outweigh harms in older adults.
What kinds of bleeding risks does aspirin raise?
Aspirin can increase bleeding risk by inhibiting platelet function (it makes blood less able to clot). The main bleeding concerns include:
- GI bleeding (for example, stomach or intestinal bleeding)
- Bleeding that leads to anemia or hospitalization
- Less commonly, serious bleeding elsewhere in the body (the risk still increases with age)
Why does age matter biologically for aspirin bleeding?
With aging, several factors increase the chance of bleeding even before any drug is taken. These include age-related changes in blood vessels and clotting, a higher likelihood of conditions that predispose to bleeding, and a greater chance of taking other medications that can amplify bleeding risk. Aspirin’s platelet effect then compounds that baseline risk.
How do other risk factors interact with age?
Age often works together with other contributors to bleeding risk, such as:
- Prior GI ulcer or GI bleeding
- Concurrent use of other blood-thinning drugs (for example, anticoagulants)
- Use of NSAIDs (other pain medicines that can irritate the stomach or affect bleeding)
- Uncontrolled high blood pressure
- Alcohol use and other medical comorbidities
In practice, clinicians estimate bleeding risk by looking at the whole profile, not age alone—older age is a strong signal, but the combined risk matters.
What should older adults consider if they’re taking aspirin?
If you’re taking aspirin (for heart disease prevention or another indication), it’s important to discuss with a clinician whether you should continue, especially if you’re older or have bleeding risk factors such as a history of ulcer/bleeding or additional blood-thinners. The decision balances preventing cardiovascular events against bleeding harms.
Is this risk different for “low-dose” versus regular-dose aspirin?
Lower-dose aspirin generally causes less bleeding than higher doses, but it still increases bleeding risk compared with no aspirin. Age continues to be important regardless of dose because the underlying bleeding susceptibility increases with age.
---
Sources: No provided sources were included with the question, so I did not cite any materials. If you share the guideline or study you’re working from (or tell me whether you mean aspirin for primary prevention vs. secondary prevention), I can tailor the answer to that context.